Cell-free DNA Genomic and Epigenomic Analysis to Predict Survival in mCRPC Patients
Offered By: Cancer Genomics Consortium via YouTube
Course Description
Overview
Explore a conference talk from the Cancer Genomics Consortium's 2023 Annual Meeting focusing on cell-free DNA analysis in metastatic castration-resistant prostate cancer (mCRPC) patients. Delve into how genomic and epigenomic analysis of cell-free DNA can be used to predict survival outcomes in mCRPC patients undergoing AR-directed therapy. Learn about the latest advancements in clinical cancer genomics and their potential impact on patient diagnosis and treatment. Gain insights from speaker Pradeep Chauhan on this cutting-edge research in the field of cancer genomics. Understand the role of organizations like the Cancer Genomics Consortium in promoting best practices and education in clinical cancer genomic testing.
Syllabus
Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients
Taught by
Cancer Genomics Consortium
Related Courses
A Practical Guide for SARS-CoV-2 Whole Genome SequencingWellcome Genome Campus via FutureLearn Algorithms for DNA Sequencing
Johns Hopkins University via Coursera Capstone Project: Advanced AI for Drug Discovery
LearnQuest via Coursera Biology Meets Programming: Bioinformatics for Beginners
University of California, San Diego via Coursera Bacterial Genomes: Antimicrobial Resistance in Bacterial Pathogens
Wellcome Genome Campus via FutureLearn